1.
Subedi S, Bahadur Dangi N, Bhattarai A. Adverse Drug Reactions of Potential Antiviral Drugs under Evaluation for the Treatment of COVID-19: Analysis of WHO Global Pharmacovigilance Database. NIJOPHASR [Internet]. 1 sept. 2021 [cité 8 nov. 2026];10(3):17-22. Disponible à: https://www.nijophasr.net/index.php/nijophasr/article/view/445